DE2451568A1 - Verfahren zur herstellung von emulgierbaren pulverfoermigen produkten - Google Patents

Verfahren zur herstellung von emulgierbaren pulverfoermigen produkten

Info

Publication number
DE2451568A1
DE2451568A1 DE19742451568 DE2451568A DE2451568A1 DE 2451568 A1 DE2451568 A1 DE 2451568A1 DE 19742451568 DE19742451568 DE 19742451568 DE 2451568 A DE2451568 A DE 2451568A DE 2451568 A1 DE2451568 A1 DE 2451568A1
Authority
DE
Germany
Prior art keywords
oil
emulsion
water
aqueous solution
nutrient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742451568
Other languages
German (de)
English (en)
Inventor
Shozo Muranishi
Hitoshi Sezaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP48121930A external-priority patent/JPS582928B2/ja
Priority claimed from JP48121929A external-priority patent/JPS582927B2/ja
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE2451568A1 publication Critical patent/DE2451568A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
DE19742451568 1973-10-30 1974-10-30 Verfahren zur herstellung von emulgierbaren pulverfoermigen produkten Pending DE2451568A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP48121930A JPS582928B2 (ja) 1973-10-30 1973-10-30 粉末製品の製造法
JP48121929A JPS582927B2 (ja) 1973-10-30 1973-10-30 フンマツセイヒンノ セイゾウホウ

Publications (1)

Publication Number Publication Date
DE2451568A1 true DE2451568A1 (de) 1975-05-07

Family

ID=26459174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742451568 Pending DE2451568A1 (de) 1973-10-30 1974-10-30 Verfahren zur herstellung von emulgierbaren pulverfoermigen produkten

Country Status (4)

Country Link
CA (1) CA1047924A (enrdf_load_stackoverflow)
DE (1) DE2451568A1 (enrdf_load_stackoverflow)
FR (1) FR2257267B1 (enrdf_load_stackoverflow)
GB (1) GB1488522A (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521565A1 (fr) * 1982-02-17 1983-08-19 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
EP0177614A4 (en) * 1984-02-13 1987-07-13 Tomita Pharma PROCESS FOR PRODUCING MIXED ELECTROLYTE POWDER FOR USE IN BICARBONATE DIALYSIS.
EP0211257A3 (en) * 1985-07-29 1987-11-19 Abbott Laboratories Lyophilized emulsion compositions
EP1864659A4 (en) * 2005-03-31 2009-08-12 Suntory Holdings Ltd A LIGNAN COMPOUND OIL-IN-WATER EMULSION AND COMPOSITION COMPRISING THEREOF
CN101856018A (zh) * 2010-06-18 2010-10-13 冀京民 醚菊酯可乳化粉剂及制造方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607717D0 (en) * 1986-03-27 1986-04-30 Unilever Plc Hydratable powders
NL2002046C (en) * 2008-10-01 2010-04-02 Friesland Brands Bv Double emulsion and method to produce such.

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521565A1 (fr) * 1982-02-17 1983-08-19 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
EP0087993A1 (fr) * 1982-02-17 1983-09-07 Parfums Christian Dior Mélange pulvérulent de constituants lipidiques et de constituants hydrophobes, procédé pour le préparer, phases lamellaires lipidiques hydratées et procédé de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratées
EP0177614A4 (en) * 1984-02-13 1987-07-13 Tomita Pharma PROCESS FOR PRODUCING MIXED ELECTROLYTE POWDER FOR USE IN BICARBONATE DIALYSIS.
EP0211257A3 (en) * 1985-07-29 1987-11-19 Abbott Laboratories Lyophilized emulsion compositions
EP1864659A4 (en) * 2005-03-31 2009-08-12 Suntory Holdings Ltd A LIGNAN COMPOUND OIL-IN-WATER EMULSION AND COMPOSITION COMPRISING THEREOF
US8685455B2 (en) 2005-03-31 2014-04-01 Suntory Holdings Limited Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
CN101856018A (zh) * 2010-06-18 2010-10-13 冀京民 醚菊酯可乳化粉剂及制造方法

Also Published As

Publication number Publication date
GB1488522A (en) 1977-10-12
FR2257267B1 (enrdf_load_stackoverflow) 1979-07-27
FR2257267A1 (enrdf_load_stackoverflow) 1975-08-08
CA1047924A (en) 1979-02-06

Similar Documents

Publication Publication Date Title
DE69526655T2 (de) Wässrige emulsion mit kontrollierter freisetzung
DE3853191T2 (de) Arzneimittelträger.
DE69524953T2 (de) Antibakterielle öl-in-wasser-emulsion
DE69328192T2 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
DE69627309T2 (de) Mizellare nanopartikeln
EP0256285B1 (de) Pharmazeutische Formulierung und Verfahren zu deren Herstellung
DE69011922T2 (de) Arzneiemulsionen.
DE69531179T2 (de) Nanoemulsion von dem Öl-in-Wasser Typ, gebrauchbar als ein ophthalmischen Vehikel und Verfahren zur seiner Herstellung
DE69914742T2 (de) Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
EP0711557A1 (de) Pharmazeutische Formulierungsgrundlage
DE3224619A1 (de) Orale pharmazeutische zusammensetzung
DE69202559T2 (de) Proliposomales pulver für polyenliposomen sowie verfahren zu dessen herstellung.
DE2601207B2 (de) Verfahren zur Herstellung einer flüssigen pharmazeutischen Zubereitung mit gesteuertem Arzneimittelabgabevermögen
EP0733372A2 (de) Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
DE2237206A1 (de) Verfahren zur herstellung von mikrokapseln
DE3435516A1 (de) Massen zur ausbildung von vesikeln
DE69505697T2 (de) Biologisch abbaubare mikrosphären mit gesteuerter freigabe und verfahren zu deren herstellung
DE69106560T2 (de) Ophthalmikum.
DE10007816A1 (de) Verfahren zur Herstellung von Nanosuspensionen
DE3852409T2 (de) Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.
DE10124952A1 (de) Verfahren zur Herstellung von Nanodispersionen
DE69431162T2 (de) Fenbendazolformulierungen
EP2066310B1 (de) Emulsionen enthaltend gummi arabicum
DE60004191T2 (de) Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung
DE2451568A1 (de) Verfahren zur herstellung von emulgierbaren pulverfoermigen produkten